Close

Amgen (AMGN) PT Lowered to $240 at Oppenheimer

March 26, 2020 6:49 AM EDT Send to a Friend
Oppenheimer analyst Jay Olson lowered the price target on Amgen (NASDAQ: AMGN) to $240.00 (from $250.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login